Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: prospective study and meta-analysis.

<h4>Background</h4>It has been suggested throughout the past fifty years that serum uric acid concentrations can help predict the future risk of coronary heart disease (CHD), but the epidemiological evidence is uncertain.<h4>Methods and findings</h4>We report a "nested&q...

Full description

Bibliographic Details
Main Authors: Jeremy G Wheeler, Kelsey D M Juzwishin, Gudny Eiriksdottir, Vilmundur Gudnason, John Danesh
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2005-03-01
Series:PLoS Medicine
Online Access:https://doi.org/10.1371/journal.pmed.0020076
_version_ 1819044345762807808
author Jeremy G Wheeler
Kelsey D M Juzwishin
Gudny Eiriksdottir
Vilmundur Gudnason
John Danesh
author_facet Jeremy G Wheeler
Kelsey D M Juzwishin
Gudny Eiriksdottir
Vilmundur Gudnason
John Danesh
author_sort Jeremy G Wheeler
collection DOAJ
description <h4>Background</h4>It has been suggested throughout the past fifty years that serum uric acid concentrations can help predict the future risk of coronary heart disease (CHD), but the epidemiological evidence is uncertain.<h4>Methods and findings</h4>We report a "nested" case-control comparison within a prospective study in Reykjavik, Iceland, using baseline values of serum uric acid in 2,456 incident CHD cases and in 3,962 age- and sex-matched controls, plus paired serum uric acid measurements taken at baseline and, on average, 12 y later in 379 participants. In addition, we conducted a meta-analysis of 15 other prospective studies in eight countries conducted in essentially general populations. Compared with individuals in the bottom third of baseline measurements of serum uric acid in the Reykjavik study, those in the top third had an age- and sex-adjusted odds ratio for CHD of 1.39 (95% confidence interval [CI], 1.23-1.58) which fell to 1.12 (CI, 0.97-1.30) after adjustment for smoking and other established risk factors. Overall, in a combined analysis of 9,458 cases and 155,084 controls in all 16 relevant prospective studies, the odds ratio was 1.13 (CI, 1.07-1.20), but it was only 1.02 (CI, 0.91-1.14) in the eight studies with more complete adjustment for possible confounders.<h4>Conclusions</h4>Measurement of serum uric acid levels is unlikely to enhance usefully the prediction of CHD, and this factor is unlikely to be a major determinant of the disease in general populations.
first_indexed 2024-12-21T10:11:12Z
format Article
id doaj.art-2245d8d892f445969ab14a11813a1cad
institution Directory Open Access Journal
issn 1549-1277
1549-1676
language English
last_indexed 2024-12-21T10:11:12Z
publishDate 2005-03-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Medicine
spelling doaj.art-2245d8d892f445969ab14a11813a1cad2022-12-21T19:07:42ZengPublic Library of Science (PLoS)PLoS Medicine1549-12771549-16762005-03-0123e7610.1371/journal.pmed.0020076Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: prospective study and meta-analysis.Jeremy G WheelerKelsey D M JuzwishinGudny EiriksdottirVilmundur GudnasonJohn Danesh<h4>Background</h4>It has been suggested throughout the past fifty years that serum uric acid concentrations can help predict the future risk of coronary heart disease (CHD), but the epidemiological evidence is uncertain.<h4>Methods and findings</h4>We report a "nested" case-control comparison within a prospective study in Reykjavik, Iceland, using baseline values of serum uric acid in 2,456 incident CHD cases and in 3,962 age- and sex-matched controls, plus paired serum uric acid measurements taken at baseline and, on average, 12 y later in 379 participants. In addition, we conducted a meta-analysis of 15 other prospective studies in eight countries conducted in essentially general populations. Compared with individuals in the bottom third of baseline measurements of serum uric acid in the Reykjavik study, those in the top third had an age- and sex-adjusted odds ratio for CHD of 1.39 (95% confidence interval [CI], 1.23-1.58) which fell to 1.12 (CI, 0.97-1.30) after adjustment for smoking and other established risk factors. Overall, in a combined analysis of 9,458 cases and 155,084 controls in all 16 relevant prospective studies, the odds ratio was 1.13 (CI, 1.07-1.20), but it was only 1.02 (CI, 0.91-1.14) in the eight studies with more complete adjustment for possible confounders.<h4>Conclusions</h4>Measurement of serum uric acid levels is unlikely to enhance usefully the prediction of CHD, and this factor is unlikely to be a major determinant of the disease in general populations.https://doi.org/10.1371/journal.pmed.0020076
spellingShingle Jeremy G Wheeler
Kelsey D M Juzwishin
Gudny Eiriksdottir
Vilmundur Gudnason
John Danesh
Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: prospective study and meta-analysis.
PLoS Medicine
title Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: prospective study and meta-analysis.
title_full Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: prospective study and meta-analysis.
title_fullStr Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: prospective study and meta-analysis.
title_full_unstemmed Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: prospective study and meta-analysis.
title_short Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: prospective study and meta-analysis.
title_sort serum uric acid and coronary heart disease in 9 458 incident cases and 155 084 controls prospective study and meta analysis
url https://doi.org/10.1371/journal.pmed.0020076
work_keys_str_mv AT jeremygwheeler serumuricacidandcoronaryheartdiseasein9458incidentcasesand155084controlsprospectivestudyandmetaanalysis
AT kelseydmjuzwishin serumuricacidandcoronaryheartdiseasein9458incidentcasesand155084controlsprospectivestudyandmetaanalysis
AT gudnyeiriksdottir serumuricacidandcoronaryheartdiseasein9458incidentcasesand155084controlsprospectivestudyandmetaanalysis
AT vilmundurgudnason serumuricacidandcoronaryheartdiseasein9458incidentcasesand155084controlsprospectivestudyandmetaanalysis
AT johndanesh serumuricacidandcoronaryheartdiseasein9458incidentcasesand155084controlsprospectivestudyandmetaanalysis